Cannabidiol: all 299 studies that test it

Page 3 of 3. Open to participants first (80), then studies with results posted, then the rest; newest registration first within each.

• Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral SolutionActive, not recruitingNCT05044819Phase 4
• Investigation of the Pharmacokinetic Profile of CBD - Phase 1 ANANDACompletedNCT05023070Phase 1
• The Effects of Cannabidiol and Homotaurine in Patients With Mild Cognitive ImpairmentStatus unknownNCT05022186Phase 4
• Investigating the Potential Role of a Novel Quadrate Combination Therapy Mifepristone(Antiprogestrone), Tamoxifen, Retinoic Acid and Cannabidiol ( Selective Cyp 26 Inhibitor) for Treating Early Breast Cancer.Status unknownNCT05016349Phase 3
• Evaluation of a Specific Transdermal Cannabidiol Product for Chronic Musculoskeletal Joint Pain.WithdrawnNCT05002114Phase 1
• Cannabinoid Tablets for the Treatment of Pain From Osteoarthritis of the KneeStatus unknownNCT04992962Phase 2
• Therapeutic Response of Cannabidiol in Rheumatoid ArthritisCompletedNCT04911127Phase 1
• Epidiolex in Typical Absence SeizuresCompletedNCT04899050Phase 4
• CBD, Immune Function, and Neural HealthCompletedNCT04881539Not applicable
• Role of CBD in Regulating Meal Time Anxiety in Anorexia NervosaActive, not recruitingNCT04878627Early Phase 1
• CBD for the Treatment of Alcohol Use DisorderCompletedNCT04873453Phase 2
• Do Adolescents and Adults Differ in Their Acute Response to Cannabis?CompletedNCT04851392Not applicable
• Effects of Cannabidiol (CBD) on the BrainActive, not recruitingNCT04831294Not applicable
• Evaluation of the Effectiveness of Cannabidiol in Treating Severe Behavioural Problems in Children and Adolescents With Intellectual DisabilityCompletedNCT04821856Phase 2
• Hippocampal Response to Acute Oral Doses of CBD During an fMRI Memory TaskActive, not recruitingNCT04778644Phase 1/2
• Sex Differences in Neural Response to CannabidiolCompletedNCT04777643Early Phase 1
• CBD for Pain Reduction and Opioid Use After Ankle and Tibia Fracture ORIFWithdrawnNCT04768478Phase 4
• The Pharmacokinetics and Pharmacodynamics of Hemp-based Topical Cannabinoid ProductsCompletedNCT04741477Phase 1
• Cannabidiol and Autonomic Function at RestCompletedNCT04731779Early Phase 1
• Cannabidiol Treatment for Severe and Critical Coronavirus (COVID-19) Pulmonary InfectionStatus unknownNCT04731116Phase 1/2
• The Study of Hemp Oil CBD for Evaluation of Efficacy and Safety in Treatment of Pain, Anxiety and Insomnia ManagementStatus unknownNCT04729244Phase 1
• Cannabidiol for Fibromyalgia (The CANNFIB Trial)CompletedNCT04729179Phase 3
• Efficacy of Epidiolex in Patients With Electrical Status Epilepticus of Sleep (ESES).CompletedNCT04721691Phase 1
• Synthetic CBD as a Therapy for COVID-19Status unknownNCT04686539Phase 1
• Using Cannabidiol to Treat Diabetic Peripheral Neuropathy of the FeetStatus unknownNCT04679545Phase 2
• Research on Cognitive Effect of Cannabidiol on Dravet Syndrome and Lennox-Gastaut SyndromeGastaut SyndromeStatus unknownNCT04611438Phase 3
• Comparative Analysis of the Effectiveness of the Use of Nimesulide and CBD Oil in Patients With Pain in the Preauricular Region Due to the Pain-dysfunctional Syndrome of the Temporomandibular Joint.Status unknownNCT04609748Phase 2
• Efficacy of Cannabidiol in Knee OsteoarthritisCompletedNCT04607603Phase 4
• Does Cannabidiol Attenuate the Acute Effects of ∆9-tetrahydrocannabinol Intoxication in Individuals Diagnosed With Schizophrenia? A Double-blind, Randomised, Placebo-controlled Experimental StudyCompletedNCT04605393Not applicable
• Cannabidiol in Opioid Use Disorder and Chronic PainCompletedNCT04587791Early Phase 1
• The Effect of Cannabidiol on Lean Body Mass in Patients Receiving ChemotherapyCompletedNCT04585841Phase 1
• A Study to Evaluate the Outcomes of Cannabinoid (CBD) Roll-on Topical Stick in Primary Total Knee ArthroplastyStatus unknownNCT04585230Not applicable
• Cannabidiol for Prevention of Chemotherapy-induced Peripheral NeuropathyStatus unknownNCT04582591Phase 2
• Neuroimaging and CBD for Opioid Use DisorderCompletedNCT04567784Phase 2
• CASCADE: CAnnabidiol Study in Children With Autism Spectrum DisordErActive, not recruitingNCT04520685Phase 2
• Trial of Cannabidiol to Treat Severe Behavior Problems in Children With AutismActive, not recruitingNCT04517799Phase 2
• Burnout and Distress preventiOn With caNnabidiol in Front-line Health Care workerS deAling wIth COVID-19CompletedNCT04504877Phase 2/3
• CANnabiDiol for CoviD-19 pATiEnts With Mild to Moderate SymptomsStatus unknownNCT04467918Phase 2/3
• Study to Evaluate the Safety, Tolerability and Efficacy of Cannabidiol (CBD) as a Steroid-sparing Therapy in Chronic Spontaneous Urticaria (CSU) PatientsCompletedNCT04439955Phase 2
• Effect of Non-psychoactive Cannabidiol as an Adjunct to Botulinum Toxin in BlepharospasmCompletedNCT04423341Phase 2/3
• The Use of Cannabinoid Patch for Knee OsteoarthritisWithdrawnNCT04412837Phase 2
• Cannabidiol and Oral Contraceptive Pills: Exploring a Drug-Drug InteractionCompletedNCT04396730Phase 4
• Efficacy of Inhaled Cannabis for Acute Migraine TreatmentCompletedNCT04360044Phase 2
• Analgesic Effects of Cannabidiol for Simple Tooth Extractions in Dental PatientsCompletedNCT04271917Phase 3
• Cannabidiol for AnxietyWithdrawnNCT04267679Phase 2
• Effects of Cannabis on Cognition and Endocannabinoid Levels in Bipolar Disorder Patients and Healthy VolunteersTerminatedNCT04231643Early Phase 1
• Cannabidiol (CBD) for the Treatment of Alcohol WithdrawalStatus unknownNCT04205682Early Phase 1
• Low Dose of Cannabidiol (CBD) to Treat Mild to Moderate Musculoskeletal PainCompletedNCT04193631Phase 1
• Investigation of Cognitive Outcomes With Cannabidiol Oral SolutionWithdrawnNCT04133480Phase 4
• A Phase 2a Study to Evaluate the Safety and Efficacy of Cannabidiol Only as Maintenance Therapy and Steroid Sparing in Patients With Stable Autoimmune HepatitisTerminatedNCT04129489Phase 2
• Cannabidiol for Treatment of Non-affective Psychosis and Cannabis UseActive, not recruitingNCT04105231Phase 2
• The Use of a Water Soluble Under the Tongue (Sublingual) CBD Tablet for Treating Pain Associated With Diabetic Peripheral NeuropathyCompletedNCT04088929Phase 2
• CHI-902 for Treatment of Social Anxiety DisorderWithdrawnNCT04086342Phase 2
• Pain Response to Cannabidiol in Opioid-induced Hyperalgesia, Acute Nociceptive Pain and Allodynia By Using a Model Mimicking Acute Pain in Healthy AdultsCompletedNCT04059978Not applicable
• Mechanisms of CBD for Chronic PainCompletedNCT04044729Early Phase 1
• Pain Response to Cannabidiol in Induced Acute Nociceptive Pain, Allodynia and Hyperalgesia By Using a Model Mimicking Acute Pain in Healthy AdultsCompletedNCT03985995Not applicable
• PAIN: A Project Assessing the Impact of a Novel Cannabinoid ProductActive, not recruitingNCT03984565Phase 2
• Cannabidiol for Alcohol Use DisorderWithdrawnNCT03904849Phase 1/2
• Effects of Cannabidiol on Psychiatric Symptoms, Cognition, and Cannabis Consumption in Cannabis Users With Recent-Onset PsychosisWithdrawnNCT03883360Phase 2
• An Open Label Study of Multiple Doses of Cannabidiol in the Prevention of Acute Graft-Versus-Host Disease (GVHD)Status unknownNCT03840512Phase 2
• CBD Treatment in Hand Osteoarthritis and Psoriatic Arthritis.CompletedNCT03693833Phase 2
• Cannabis Oil for Chronic Non-Cancer Pain TreatmentStatus unknownNCT03635593Phase 2
• Cannabidiol in Patients With Heart Failure Failure in AHA/ACC Stages A-CStatus unknownNCT03634189Phase 1
• A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI MalignanciesStatus unknownNCT03607643Phase 1/2
• Shifting Brain Excitation-Inhibition Balance in Autism Spectrum DisorderCompletedNCT03537950Not applicable
• Cannabidiol and Prolonged ExposureCompletedNCT03518801Phase 2
• Cannabidiol - an in Vivo Innovative Drug Delivery StudyTerminatedNCT03471559Phase 1
• Cannabidiol Usage as an Adjunct Therapy for Crohn's DiseaseWithdrawnNCT03467620Phase 2/3
• A Study to Assess the Safety and Tolerability of ZX008 in Children and Young Adults With Dravet Syndrome or Lennox Gastaut Syndrome Currently Taking CannabidiolCompletedNCT03467113Phase 1
• Cannabidiol as an Adjunctive Treatment for Bipolar DepressionTerminatedNCT03310593Phase 2/3
• Treatment of Chronic Pain With Cannabidiol (CBD) and Delta-9-tetrahydrocannabinol (THC)CompletedNCT03215940Early Phase 1
• Endocannabinoid Control of Microglia Activation as a New Therapeutic Target in the Treatment of SchizophreniaCompletedNCT02932605Not applicable
• A Double-Blind Trial to Evaluate Efficacy and Safety of Cannabidiol as an add-on Therapy for Treatment in Refractory EpilepsyActive, not recruitingNCT02783092Phase 3
• An Open-label Extension Trial to Investigate Possible Drug-drug Interactions Between Stiripentol or Valproate and Cannabidiol in Patients With EpilepsyCompletedNCT02607904Phase 2
• A Study of Possible Drug-drug Interactions Between Stiripentol or Valproate and Cannabidiol in Patients With EpilepsyCompletedNCT02607891Phase 2
• Cannabidiol and Cocaine Craving/DependenceCompletedNCT02559167Phase 2
• Gene-Environment-Interaction: Influence of the COMT Genotype on the Effects of Different Cannabinoids - a PET StudyWithdrawnNCT02492074Phase 1
• Gene-Environment-Interaction: Influence of the COMT Genotype on the Effects of Different CannabinoidsCompletedNCT02487381Phase 1
• Extended Use of Cannabidiol for the Prevention of Graft-versus-host-diseaseStatus unknownNCT02478424Phase 2
• Cannabidiol for the Treatment of Severe (Grades III/IV) Acute Graft-versus-host DiseaseStatus unknownNCT02392780Phase 2
• Cannabidiol Oral Solution as an Adjunctive Therapy for Treatment of Participants With Inadequately Controlled Dravet SyndromeWithdrawnNCT02318563Phase 3
• Cannabidiol Oral Solution as an Adjunctive Therapy for Treatment of Participants With Inadequately Controlled Lennox-Gastaut SyndromeWithdrawnNCT02318537Phase 3
• Effects of THC and CBD on Human Episodic Memory FunctionCompletedNCT02291562Not applicable
• Processing of Salient Emotional Stimuli as a Function of Tetrahydrocannabinol (THC) and Cannabidiol (CBD)CompletedNCT02291536Not applicable
• Cannabidiol (CBD) to 27 Patients (Aged 2 Years - 19 Years) With Drug Resistant EpilepsyCompletedNCT02286986Phase 1
• A Study: Pure CBD as Single-agent for Solid Tumor.Status unknownNCT02255292Phase 2
• The Role of the Endocannabinoid System in Sweet Taste Intensity and LikingCompletedNCT02112292Not applicable
• A Four-week Clinical Trial Investigating Efficacy and Safety of Cannabidiol As a Treatment for Acutely Ill Schizophrenic PatientsTerminatedNCT02088060Phase 2
• Cannabidiol (CBD) for the Management of Cannabis Withdrawal: A Phase II Proof of Concept StudyStatus unknownNCT02083874Phase 2
• Study of the Glutaminase Inhibitor CB-839 in Solid TumorsCompletedNCT02071862Phase 1
• Cannabidiol as a Different Type of an Antipsychotic: Drug Delivery and Interaction StudyCompletedNCT02051387Phase 1
• Cannabidiol: a Novel Intervention for Cannabis Use Problems?CompletedNCT02044809Phase 2
• Safety and Efficacy of Cannabidiol for Grade I/II Acute Graft Versus Host Disease (GVHD) After Allogeneic Stem Cell TransplantationStatus unknownNCT01596075Phase 1/2
• Neuroprotection by Cannabinoids in Huntington's DiseaseCompletedNCT01502046Phase 2
• Cannabidiol for Graft Versus Host Disease (GVHD) Prophylaxis in Allogeneic Stem Cell TransplantationStatus unknownNCT01385124Phase 1/2
• Study to Test the Safety and Efficacy of Cannabidiol as a Treatment Intervention for Opioid RelapseCompletedNCT01311778Phase 1
• The Effects of Cannabidiol and ∆-9-THC in HumansCompletedNCT01180374Early Phase 1
• Cannabidiol for Inflammatory Bowel DiseaseCompletedNCT01037322Phase 1/2
• Evaluation of the Antipsychotic Efficacy of Cannabidiol in Acute Schizophrenic PsychosisCompletedNCT00628290Phase 2

← Cannabidiol overview